Pharmafile Logo

News and Press Releases

Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress

Preclinical data demonstrates proof-of-concept for EDIT-401 with ≥90% mean LDL-C reduction in non-human primates and mouse models 9 October 2025 -- Massachusetts, US -- Editas Medicine, Inc, a pioneering gene editing company,...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: October 9, 2025

Editas Medicine
info@editasmed.com
11 Hurley Street Cambridge, MA 02141 617.401.9000

Novonesis probiotic strain receives health claim in Canada

Health Canada authorizes functional claims that the new probiotic strain CLEPIUS™ “helps alleviate perceived stress and improve irritable bowel syndrome-related quality of life in adults” 11 March 2024 -- Copenhagen,...

Category: Biotechnology, Other, Pharmaceutical
Posted: March 11, 2025

Novonesis
Biologiens Vej 2 2800 Lyngby Denmark

Yourgene Health Launches IONA Care+ Non-invasive Prenatal Testing Service

Offers expectant parents fully comprehensive prenatal screening test for genetic conditions, including microdeletions 13 February 2025 -- Manchester, UK -- Yourgene Health (part of the Novacyt group of companies), a leading...

Category: Biotechnology, Other, Pharmaceutical
Posted: February 13, 2025

Yourgene Health
info@yourgenehealth.com
Skelton House Lloyd Street North Manchester Science Park M15 6SH United Kingdom

PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics

14 January 2025 – Menlo Park, California US – PacBio (NASDAQ: PACB), a leading provider of highly accurate long-read sequencing solutions, announced a significant publication from Radboud University Medical Center...

Category:
Posted: January 16, 2025

PacBio
support@pacb.com
1305 O’Brien Drive Menlo Park, CA 94025

Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials

9 January 2025 -- Cambridge, UK and Montreal, Canada -- Biofidelity, a leader in innovative genomic solutions, and CellCarta, the global contract research organization (CRO) partner of choice for biopharmaceutical...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: January 9, 2025

Biofidelity
5151 McCrimmon Parkway, Suite 230 Morrisville, NC 27560

Broken String Biosciences appoints Steve Becker as Chief Commercial Officer

Appointment brings extensive experience to lead commercial operations and accelerate growth in key global markets Cambridge, UK, 24 July 2024: Broken String Biosciences (“Broken String”), a genomics company driving development...

Category: BioManufacturing
Posted: July 24, 2024

Broken String Biosciences
info@brokenstringbio.com
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR

Deep Genomics Expands Executive Leadership and Operations in Latest Strategic Growth Initiative  

Company announces executive new hires and marks significant momentum with Cambridge, Massachusetts, US, site opening and Toronto, Canada, office expansion   13 June 2024 -- Massachusetts, US -- Deep Genomics, the...

Category: Biotechnology, Other, Pharmaceutical
Posted: June 13, 2024

Deep Genomics
press@deepgenomics.com
480 University Ave, Suite 1300 Toronto, Ontario, Canada, M5G 1V2

ERS Genomics and IRBM sign CRISPR/Cas9 license agreement

License agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering 20 May 2024 -- Dublin, Ireland, and Rome, Italy -- ERS...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: May 20, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

First Study Using Biomimetic AI Digital Twins And Multiomics in Genetics Research

Paper on the ground-breaking research by Genzeva, LumaGene, RYLTI, Brigham & Women’s Hospital of Harvard University, and QIAGEN Digital Insights was published this week in the Journal of Molecular Diagnostics 3 April...

Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: April 3, 2024

GENZEVA
hello@genzeva.com
9420 Key West Avenue, Suite 100, Rockville, Maryland

Broken String Biosciences’ INDUCE-seq platform demonstrates impact of structural DNA changes on specificity of CRISPR-Cas9 gene editing

Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity Peer-reviewed data demonstrates the sensitivity of INDUCE-seq DNA break mapping platform,...

Category: Biotechnology
Posted: October 18, 2023

Broken String Biosciences
info@brokenstringbio.com
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR